Skip to main content
NCBI home page
Gut logoLink to Gut
. 1993 Dec;34(12):1683–1687. doi: 10.1136/gut.34.12.1683

DNA damage in the stomach after vagotomy measured by 32P-postlabelling.

G W Dyke 1, J L Craven 1, R Hall 1, R C Garner 1
PMCID: PMC1374463  PMID: 8282256

Abstract

This study analysed gastric mucosal DNA by 32P-postlabelling in a series of patients who have had previous vagotomy for benign peptic ulcer disease. DNA adduct levels were found to be significantly higher in patients who had had previous truncal vagotomy than in those who had had previous highly selective vagotomy (p < 0.001). Intragastric bile concentrations were also considerably higher in patients after truncal vagotomy but there was no correlation between intragastric bile concentrations and DNA adduct levels. These results suggest that, although duodenogastric reflux may be a cause of gastric mucosal DNA damage in the stomach after vagotomy, measurement of total intragastric bile does not accurately reflect genotoxic insult.

Full text

PDF
1683

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdulnur S. F., Flurry R. L., Jr Effect of guanine alkylation on mispairing. Nature. 1976 Nov 25;264(5584):369–370. doi: 10.1038/264369a0. [DOI] [PubMed] [Google Scholar]
  2. Amdrup E., Jensen H. E. Selective vagotomy of the parietal cell mass preserving innervation of the undrained antrum. A preliminary report of results in patients with duodenal ulcer. Gastroenterology. 1970 Oct;59(4):522–527. [PubMed] [Google Scholar]
  3. BROOKES P., LAWLEY P. D. EVIDENCE FOR THE BINDING OF POLYNUCLEAR AROMATIC HYDROCARBONS TO THE NUCLEIC ACIDS OF MOUSE SKIN: RELATION BETWEEN CARCINOGENIC POWER OF HYDROCARBONS AND THEIR BINDING TO DEOXYRIBONUCLEIC ACID. Nature. 1964 May 23;202:781–784. doi: 10.1038/202781a0. [DOI] [PubMed] [Google Scholar]
  4. Caygill C. P., Hill M. J., Kirkham J. S., Northfield T. C. Mortality from gastric cancer following gastric surgery for peptic ulcer. Lancet. 1986 Apr 26;1(8487):929–931. doi: 10.1016/s0140-6736(86)91041-x. [DOI] [PubMed] [Google Scholar]
  5. Cuzick J., Routledge M. N., Jenkins D., Garner R. C. DNA adducts in different tissues of smokers and non-smokers. Int J Cancer. 1990 Apr 15;45(4):673–678. doi: 10.1002/ijc.2910450417. [DOI] [PubMed] [Google Scholar]
  6. Dyke G. W., Craven J. L., Hall R., Garner R. C. Smoking-related DNA adducts in human gastric cancers. Int J Cancer. 1992 Dec 2;52(6):847–850. doi: 10.1002/ijc.2910520602. [DOI] [PubMed] [Google Scholar]
  7. Goth R., Rajewsky M. F. Persistence of O6-ethylguanine in rat-brain DNA: correlation with nervous system-specific carcinogenesis by ethylnitrosourea. Proc Natl Acad Sci U S A. 1974 Mar;71(3):639–643. doi: 10.1073/pnas.71.3.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gupta R. C. Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts. Cancer Res. 1985 Nov;45(11 Pt 2):5656–5662. [PubMed] [Google Scholar]
  9. Gupta R. C. Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc Natl Acad Sci U S A. 1984 Nov;81(22):6943–6947. doi: 10.1073/pnas.81.22.6943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gupta R. C., Reddy M. V., Randerath K. 32P-postlabeling analysis of non-radioactive aromatic carcinogen--DNA adducts. Carcinogenesis. 1982;3(9):1081–1092. doi: 10.1093/carcin/3.9.1081. [DOI] [PubMed] [Google Scholar]
  11. Hemminki K. Nucleic acid adducts of chemical carcinogens and mutagens. Arch Toxicol. 1983 Apr;52(4):249–285. doi: 10.1007/BF00316495. [DOI] [PubMed] [Google Scholar]
  12. Hirayama T. Epidemiology of cancer of the stomach with special reference to its recent decrease in Japan. Cancer Res. 1975 Nov;35(11 Pt 2):3460–3463. [PubMed] [Google Scholar]
  13. Houghton P. W., Leaper D. J. Gastric cancer following highly selective vagotomy. Postgrad Med J. 1987 Jan;63(735):47–48. doi: 10.1136/pgmj.63.735.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Howson C. P., Hiyama T., Wynder E. L. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev. 1986;8:1–27. doi: 10.1093/oxfordjournals.epirev.a036288. [DOI] [PubMed] [Google Scholar]
  15. Johnson R. A., Walseth T. F. The enzymatic preparation of [alpha-32P]ATP, [alpha-32P]GTP, [32P]cAMP, and [32P]cGMP, and their use in the assay of adenylate and guanylate cyclases and cyclic nucleotide phosphodiesterases. Adv Cyclic Nucleotide Res. 1979;10:135–167. [PubMed] [Google Scholar]
  16. Johnston D., Wilkinson A. R. Highly selective vagotomy without a drainage procedure in the treatment of duodenal ulcer. Br J Surg. 1970 Apr;57(4):289–296. doi: 10.1002/bjs.1800570414. [DOI] [PubMed] [Google Scholar]
  17. Koruth N. M., Dua K. S., Brunt P. W., Matheson N. A. Comparison of highly selective vagotomy with truncal vagotomy and pyloroplasty: results at 8-15 years. Br J Surg. 1990 Jan;77(1):70–72. doi: 10.1002/bjs.1800770125. [DOI] [PubMed] [Google Scholar]
  18. Lehnert T., Deschner E. E., Ivankovic S., DeCosse J. J. Promotion of gastric tumorigenesis by duodenal contents in rats induced with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Surgery. 1988 Jun;103(6):643–647. [PubMed] [Google Scholar]
  19. Macintyre I. M., Millar A., Smith A. N., Small W. P. Highly selective vagotomy 5-15 years on. Br J Surg. 1990 Jan;77(1):65–69. doi: 10.1002/bjs.1800770124. [DOI] [PubMed] [Google Scholar]
  20. Meijer S., Visser J. J., Rauwerda J., Hoitsma H. F. Effect of selective proximal and truncal vagotomy on canine gallbladder bile composition. Eur Surg Res. 1981;13(2):134–142. doi: 10.1159/000128179. [DOI] [PubMed] [Google Scholar]
  21. Miller E. C., Miller J. A. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer. 1981 May 15;47(10):2327–2345. doi: 10.1002/1097-0142(19810515)47:10<2327::aid-cncr2820471003>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  22. Nomura A., Grove J. S., Stemmermann G. N., Severson R. K. A prospective study of stomach cancer and its relation to diet, cigarettes, and alcohol consumption. Cancer Res. 1990 Feb 1;50(3):627–631. [PubMed] [Google Scholar]
  23. Phillips D. H., Hewer A., Martin C. N., Garner R. C., King M. M. Correlation of DNA adduct levels in human lung with cigarette smoking. Nature. 1988 Dec 22;336(6201):790–792. doi: 10.1038/336790a0. [DOI] [PubMed] [Google Scholar]
  24. Quintanilla M., Brown K., Ramsden M., Balmain A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature. 1986 Jul 3;322(6074):78–80. doi: 10.1038/322078a0. [DOI] [PubMed] [Google Scholar]
  25. Randerath E., Miller R. H., Mittal D., Avitts T. A., Dunsford H. A., Randerath K. Covalent DNA damage in tissues of cigarette smokers as determined by 32P-postlabeling assay. J Natl Cancer Inst. 1989 Mar 1;81(5):341–347. doi: 10.1093/jnci/81.5.341. [DOI] [PubMed] [Google Scholar]
  26. Randerath K., Reddy M. V., Gupta R. C. 32P-labeling test for DNA damage. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6126–6129. doi: 10.1073/pnas.78.10.6126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Reddy B. S., Watanabe K., Weisburger J. H., Wynder E. L. Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res. 1977 Sep;37(9):3238–3242. [PubMed] [Google Scholar]
  28. Reddy M. V., Randerath K. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis. 1986 Sep;7(9):1543–1551. doi: 10.1093/carcin/7.9.1543. [DOI] [PubMed] [Google Scholar]
  29. Routledge M. N., Orton T. C., Lord P. G., Garner R. C. Effect of butylated hydroxyanisole on the level of DNA adduction by aristolochic acid in the rat forestomach and liver. Jpn J Cancer Res. 1990 Mar;81(3):220–224. doi: 10.1111/j.1349-7006.1990.tb02553.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Spigelman A. D., Scates D. K., Venitt S., Phillips R. K. DNA adducts, detected by 32P-postlabelling, in the foregut of patients with familial adenomatous polyposis and in unaffected controls. Carcinogenesis. 1991 Sep;12(9):1727–1732. doi: 10.1093/carcin/12.9.1727. [DOI] [PubMed] [Google Scholar]
  31. Staël von Holstein C., Graffner H., Oscarson J. One hundred patients ten years after parietal cell vagotomy. Br J Surg. 1987 Feb;74(2):101–103. doi: 10.1002/bjs.1800740209. [DOI] [PubMed] [Google Scholar]
  32. Sukumar S., Notario V., Martin-Zanca D., Barbacid M. Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations. Nature. 1983 Dec 15;306(5944):658–661. doi: 10.1038/306658a0. [DOI] [PubMed] [Google Scholar]
  33. Toftgaard C. Gastric cancer after peptic ulcer surgery. A historic prospective cohort investigation. Ann Surg. 1989 Aug;210(2):159–164. doi: 10.1097/00000658-198908000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Watt P. C., Sloan J. M., Spencer A., Kennedy T. L. Histology of the postoperative stomach before and after diversion of bile. Br Med J (Clin Res Ed) 1983 Nov 12;287(6403):1410–1412. doi: 10.1136/bmj.287.6403.1410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wu-Williams A. H., Yu M. C., Mack T. M. Life-style, workplace, and stomach cancer by subsite in young men of Los Angeles County. Cancer Res. 1990 May 1;50(9):2569–2576. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES